Accrufer has a total of 3 drug patents. A generic version of the drug could be released after the final patent expires on 23 October, 2035. It's important to note that drug patent challenges against Accrufer can begin from 26 July, 2023, further influencing the availability date of Accrufer generics.
Accrufer is used to treat iron deficiency. Its effectiveness is attributed to its active ingredient, ferric maltol, which helps in increasing the iron levels in the body. Accrufer is available in capsule form for oral administration.
Accrufer holds 3 patents with the last one expiring on 23rd October, 2035. These patents protect the unique composition and dosage regimens of the drug, impacting the release date of Accrufer generic. Below are the details of the patents: